First Publication of Integrated Report 2022
First written in FY2023-Q1. 2 of 3 entries say "Restated". Latest entry: FY2023-Q3.
1 other company's latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「⑤ Issued the group’s first “Integrated Report 2022”」
The first issuance of Integrated Report 2022 is being reaffirmed as an initiative for disclosing information on sustainable growth and sustainability. - FY2023-Q2RestatedAnnual report
「As an initiative toward achieving this, during the cumulative second quarter consolidated period the company issued ③ its first “Integrated Report 2022” as a group.」
The first issuance of Integrated Report 2022 is being reaffirmed as an initiative for disclosing information on sustainable growth and sustainability. - FY2023-Q1First statedAnnual report
「As measures toward achieving this, during the three months ended the first quarter, we entered into ① a basic agreement for the exclusive distribution in Japan of Penumbra Inc.’s (U.S.) thrombus aspiration devices for peripheral vessels, ② an exclusive distribution agreement in China for DK MEDTECH (Suzhou) Co., Ltd.’s “DK Score coronary scoring balloon dilatation catheter,” and ③ issued the Group’s first “Integrated Report 2022.”」
For the first time as a group, the company issued Integrated Report 2022, integrating disclosure of information on its growth strategy, management foundation and sustainability.